OVIT (OncoVista Innovative Therapies) LT-Debt-to-Total-Asset: 0.00 (As of Sep. 2015)


What is OncoVista Innovative Therapies LT-Debt-to-Total-Asset?

OncoVista Innovative Therapies OVIT LT-Debt-to-Total-Asset is 0.00 as of Sep. 2015.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. OncoVista Innovative Therapies's long-term debt to total assests ratio for the quarter that ended in Sep. 2015 was 0.00.

OncoVista Innovative Therapies's long-term debt to total assets ratio stayed the same from Sep. 2014 (0.00) to Sep. 2015 (0.00).

OncoVista Innovative Therapies  (OTCPK:OVIT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

OncoVista Innovative Therapies LT-Debt-to-Total-Asset Related Terms

OncoVista Innovative Therapies LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies LT-Debt-to-Total-Asset Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies LT-Debt-to-Total-Asset Calculation

OncoVista Innovative Therapies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2014 is calculated as

LT Debt to Total Assets (A: Dec. 2014 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2014 )/Total Assets (A: Dec. 2014 )
=0/0.013
=

OncoVista Innovative Therapies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2015 is calculated as

LT Debt to Total Assets (Q: Sep. 2015 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2015 )/Total Assets (Q: Sep. 2015 )
=0/0.061
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
OncoVista Innovative Therapies (OVIT) has a LT-Debt-to-Total-Asset of 0.00 as of Sep. 2015. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' LT-Debt-to-Total-Asset too high?
OncoVista Innovative Therapies' current LT-Debt-to-Total-Asset is 0.00.
How does OncoVista Innovative Therapies' LT-Debt-to-Total-Asset compare to RSPI and HSTC?
OncoVista Innovative Therapies' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current LT-Debt-to-Total-Asset is 0.00 as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.